Bank of New York Mellon’s Biocept, Inc. BIOC Stock Holding History
Bought
Maintained
Sold
Other funds holding BIOC
HSA
SM
GCP
Bank of New York Mellon's BIOC Position: Q1 2021 in Review
Bank of New York Mellon sold out of Biocept, Inc. (BIOC) in Q1 2021, closing a stake of 541 shares — an estimated $72K sold.
Bank of New York Mellon first reported a position in BIOC in Q1 2017 and held it in 7 quarters. The position peaked at $77K in Q1 2017. 22 funds tracked by Wall St. Rank hold BIOC as of Q1 2021.
- Bank of New York Mellon reported no remaining Biocept, Inc. position as of Q1 2021 after selling out during the quarter.
- Bank of New York Mellon sold 541 Biocept, Inc. shares in Q1 2021, an estimated $72K.
- Bank of New York Mellon first reported a position in Biocept, Inc. in Q1 2017 and held it in 7 quarters.
- Bank of New York Mellon's Biocept, Inc. position peaked at $77K in Q1 2017.
- 22 funds tracked by Wall St. Rank held Biocept, Inc. as of Q1 2021.
Based on Bank of New York Mellon's 13F filing for Q1 2021, filed 13 May 2021.